The 2 analysts offering 12-month price forecasts for Tenax Therapeutics Inc have a median target of 4.75, with a high estimate of 5.00 and a low estimate of 4.50. The median estimate represents a +278.49% increase from the last price of 1.25.
The current consensus among 1 polled investment analysts is to Buy stock in Tenax Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.16
Reporting Date Apr 04
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.